Severe Hypertriglyceridemia Presenting as Superior Sagittal Sinus Thrombosis

Authors

  • Debmalya Sanyal Kali Pradip Chaudhari Medical College, Kolkata
  • Soumyabrata Roy Chaudhuri
  • Anirban Majumder

Abstract

We report a case of a 38-year-old Indian male who presented with severe throbbing headache spreading diffusely from occipital to nuchal regions. He was detected to have superior cerebral (sagittal) venous sinus thrombosis (CVST) with severe hypertriglyceridemia without any coagulation abnormalities or autoimmune disease. Our case highlights the need for clinicians to consider CVST among patients with uncontrolled hypertriglyceridemia. New prognostic measures may become necessary having an implication on the risk of recurrence and duration of anticoagulant therapy in CVST.

Downloads

Download data is not yet available.

References

Stam J. Thrombosis of the cerebral veins and sinuses. New Engl J Med.2005; 352:1791-98. http://dx.doi.org/10.1056/NEJMra042354.

Bousser MG, Chiras J, Bories J, et al. Cerebral venous thrombosis – a review of 38 cases. Stroke.1985; 16:199-213.http://dx.doi.org/10.1161/01.STR.16.2.199.

Allroggen H, Abbott RJ. Cerebral venous sinus thrombosis. Postgrad Med J. 2000; 76:12-15.

http://dx.doi.org/10.1136/pmj.76.891.12.

Kamphuisen PW, Eikenboom JC, vos HL, et al. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.ThrombHaemost. 1999; 81(5):680-683.

T-Y. Wang, J Yen, G-Y Hung, M-Y Hsieh, R-B Tang. A rare complication in a child undergoing chemotherapy for acute lymphoblastic leukemia: Superior sagittal sinus thrombosis. Journal of the Chinese Medical Association. 2011; 74:183-187. http://dx.doi.org/10.1016/j.jcma.2011.01.041.

Doggen CJM, Smith NL, Lemaitre RN, Heckbert SR, Rosendaal FR, Psaty BM. Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol. 2004;24:1970 –1975. http://dx.doi.org/10.1161/01.ATV.0000143134.87051.46.

Candelaria GTB, Belangero VMS. "Predisposing factors for deep venous thrombosis in children and adolescents with nephrotic syndrome," ISRN Vascular Medicine. 2011; 1-5. http://dx.doi.org/10.5402/2011/827483.

Saxena R, Batra V, Singh ND, "Prothrombotic factors in nephrotic syndrome." Indian Journal of Pathology and Microbiology. 2000; 43(3)319–323.

García-Raso A, Santos Montero AB, Ene GS, Llamas Sillero P. Cardiovascular risk factors and venous thromboembolism: Is there a connection? J Hematol Transfus. 2013; 1(2): 1009.

Ciccone A, Canhão P, Falcão F, et al. Thrombolysis for cerebral vein and dural sinus thrombosis. Cochrane Database Syst Rev. 2004; (1):CD003693.

de Bruijn SFTM, Stam J, for the Cerebral Venous Thrombosis Study Group. Randomised, placebo-controlled trial of anticoagulation treatment with low-molecular-weight heparin for cerebral sinus

thrombosis. Stroke. 1999; 30: 484–488.

http://dx.doi.org/10.1161/01.STR.30.3.484.

van Nuenen BFL, Munneke M, Bloem BR. Cerebral venous sinus thrombosis: Prevention of recurrent thromboembolism. Stroke. 2005;

: 1822. http://dx.doi.org/10.1161/01.STR.0000176582.17934.82.

Mertens I, Verrijken A. Michiels JJ, et al. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. International Journal of Obesity. 2006; 30: 1308–1314.

http://dx.doi.org/10.1038/sj.ijo.0803189.

Published

2014-11-29

How to Cite

Sanyal, D., Chaudhuri, S. R., & Majumder, A. (2014). Severe Hypertriglyceridemia Presenting as Superior Sagittal Sinus Thrombosis. Journal of the ASEAN Federation of Endocrine Societies, 29(2), 190. Retrieved from https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/138

Issue

Section

Case Reports